Article type
Abstract
"Background: Cancer patients receiving chemotherapy or radiotherapy can easily lead to oral mucositis, infection, pain, malnutrition, or xerostomia, etc. These can cause the length of hospitalization and medical costs and reduces the patient's quality of life. Based on the TVGH EBM framework, a five-phase clinical practice guideline development was updated.
Objective: The purpose of this study was to update a clinical practice guideline for providing oral care in chemotherapy and radiotherapy cancer patients in an acute care hospital in Taiwan.
Methods: Five phases design was used to develop the clinical practice guideline: In Phase I, the relevant multidisciplinary health care team members were invited to participate in the planning of the clinical guideline development working group. In Phase II, comprehensive systematic reviews were conducted. The potential articles were searching from data sources such as Cochrane Library, CINAHL, OVID, PubMed, ProQuest, Joanna Briggs Institute Best Practice Guidelines et al. Totally 33 studies had retrieved including 26 systematic reviews and 7 clinical guidelines during 2012-2023. In Phase III, the Joanna Briggs Institute Critical Appraisal Tool for Systematic Reviews was used to appraise the systematic reviews and the Appraisal of Guidelines for Research & Evaluation (AGREE II) was used to appraise the clinical guidelines. In phase IV, a focus group including 6 patients and 8 health care team members were conduct to understand their experiences for cancer patients oral care in hospital. In phase V, a survey was conducted to measure the feasibility of the clinical guideline which was built by the outcomes from phase III and IV. Totally, there were 46 clinical health care members from hospital setting were invited to fill out the questionnaire.
Results: (1) The overall agreement from clinical members was 85.4%; (2) A totally 73-item clinical guideline was developed including 8 domains: oral assessment, oral hygiene, interventions for treating oral mucositis, pain care, nutrition support, xerostomia care, oral candidiasis care, and herpes simplex virus care.
Conclusions: These results might provide clinical administrators with actionable recommendations that can be used to ensure cancer patient care safety, and to provide the evidence-based information for all health medical staff."
Objective: The purpose of this study was to update a clinical practice guideline for providing oral care in chemotherapy and radiotherapy cancer patients in an acute care hospital in Taiwan.
Methods: Five phases design was used to develop the clinical practice guideline: In Phase I, the relevant multidisciplinary health care team members were invited to participate in the planning of the clinical guideline development working group. In Phase II, comprehensive systematic reviews were conducted. The potential articles were searching from data sources such as Cochrane Library, CINAHL, OVID, PubMed, ProQuest, Joanna Briggs Institute Best Practice Guidelines et al. Totally 33 studies had retrieved including 26 systematic reviews and 7 clinical guidelines during 2012-2023. In Phase III, the Joanna Briggs Institute Critical Appraisal Tool for Systematic Reviews was used to appraise the systematic reviews and the Appraisal of Guidelines for Research & Evaluation (AGREE II) was used to appraise the clinical guidelines. In phase IV, a focus group including 6 patients and 8 health care team members were conduct to understand their experiences for cancer patients oral care in hospital. In phase V, a survey was conducted to measure the feasibility of the clinical guideline which was built by the outcomes from phase III and IV. Totally, there were 46 clinical health care members from hospital setting were invited to fill out the questionnaire.
Results: (1) The overall agreement from clinical members was 85.4%; (2) A totally 73-item clinical guideline was developed including 8 domains: oral assessment, oral hygiene, interventions for treating oral mucositis, pain care, nutrition support, xerostomia care, oral candidiasis care, and herpes simplex virus care.
Conclusions: These results might provide clinical administrators with actionable recommendations that can be used to ensure cancer patient care safety, and to provide the evidence-based information for all health medical staff."